United States · FDA National Drug Code directory
Ciprofloxacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85766-100_5031c86c-38c0-9587-e063-6294a90afff2
- Product NDC
- 85766-100
- Form
- TABLET
- Composition / generic term
- Ciprofolxacin
- Labeler
- Sportpharm LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231001
- Source listing expiry
- 20271231
Source-listed ingredients
- CIPROFLOXACIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (85766-100-01) · 85766-100-01
- 10 TABLET in 1 BOTTLE (85766-100-10) · 85766-100-10
- 20 TABLET in 1 BOTTLE (85766-100-20) · 85766-100-20
- 30 TABLET in 1 BOTTLE (85766-100-30) · 85766-100-30
- 60 TABLET in 1 BOTTLE (85766-100-60) · 85766-100-60
- 90 TABLET in 1 BOTTLE (85766-100-90) · 85766-100-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →